Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
THE pharmaceutical industry is considering a radical shift in the way it prices drugs in Europe so companies are rewarded for the clinical benefit of treatments rather than the number of pills sold, according to an internal report.
The high price of drugs is straining Europe